Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer treated with brachytherapy and supplemental external beam

被引:0
|
作者
Allen, Z.
Merrick, G. S.
Butler, W.
Wallner, K.
Galbreath, R.
Adamovich, E.
Lief, J.
机构
[1] Wheeling Hosp, Wheeling, WV USA
[2] Puget Sound Healthcare Cooperat, Grp Hlth, Seattle, WA USA
[3] Ohio Univ Eastern, St Clairsville, OH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
15578
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer
    McCall, Neal S.
    Liu, Yuan
    Patel, Sagar A.
    Hershatter, Bruce
    Moghanaki, Drew
    Godette, Karen D.
    Hanasoge, Sheela
    Patel, Pretesh
    Fischer-Valuck, Benjamin W.
    Shelton, Joseph W.
    Jani, Ashesh B.
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (06)
  • [32] Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients with Localized, High-Risk Prostate Cancer
    McCall, N. S.
    Liu, Y.
    Patel, S. A.
    Hershatter, B.
    Moghanaki, D.
    Godette, K. D.
    Hanasoge, S.
    Patel, P. R.
    Fischer-Valuck, B. W.
    Shelton, J. W.
    Jani, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E877 - E877
  • [33] Overall survival for men with high risk prostate cancer and co-morbidities after treatment with external beam radiotherapy and androgen deprivation therapy.
    Taku, Nicolette
    Narayan, Vivek
    Vapiwala, Neha
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Overall Survival for Men with High Risk Prostate Cancer and Co-Morbidities after Treatment with External Beam Radiation Therapy and Androgen Deprivation Therapy Versus External Beam Radiation Therapy Alone
    Taku, N.
    Narayan, V.
    Vapiwala, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E144 - E145
  • [36] Impact of therapy on gene expression in high-risk prostate cancer (PCA) treated with neoadjuvant docetaxel and androgen deprivation therapy
    Beltran, Himisha
    Wyatt, Alexander
    Chedgy, Edmund
    Fazli, Ladan
    Sboner, Andrea
    Halabi, Susan
    Gleave, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [37] Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review
    Berdine L. Heesterman
    Katja K. H. Aben
    Igle Jan de Jong
    Floris J. Pos
    Olga L. van der Hel
    BMC Cancer, 23
  • [38] Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review
    Heesterman, Berdine L.
    Aben, Katja K. H.
    de Jong, Igle Jan
    Pos, Floris J.
    van der Hel, Olga L.
    BMC CANCER, 2023, 23 (01)
  • [39] HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation for intermediate and high risk prostate cancer
    Kurek, R
    Martin, T
    Röddiger, SJ
    Sapoutzis, N
    Dannenberg, T
    Rogge, B
    Baltas, W
    Tunn, UW
    Zamboglou, N
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 70 - 70
  • [40] High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term androgen deprivation therapy for very high-risk prostate cancer
    Kasahara, Takashi
    Ishizaki, Fumio
    Kazama, Akira
    Yuki, Eri
    Yamana, Kazutoshi
    Maruyama, Ryo
    Oshikane, Tomoya
    Kaidu, Motoki
    Aoyama, Hidefumi
    Bilim, Vladimir
    Nishiyama, Tsutomu
    Tomita, Yoshihiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (09) : 800 - 806